BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.

Latest. Sanofi opens 'world first' mod­u­lar vac­cines and bi­o­log­ics fac­to­ry in France. 5 minutes ago. Manufacturing. For­mer Ver­i­ly ex­ecs launch ef­fort to trans­form clin­i­cal tri­als....

Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.

The US Food and Drug Administration (FDA) approved a record-breaking 71 new medicines in 2023. There were one or two controversial decisions and a slight drop in first-in-class approvals.

Coherus stressed that the supply squeeze is solely related to labeling and packaging and does not concern the availability or supply of Udenyca's active pharmaceutical ingredient. Manufacturing ...

Pharma Manufacturing provides news, analysis and examples of how leading pharmaceutical companies are tackling drug development, scale-up and manufacturing challenges.

Trendline. Inside the market of emerging biotech. New biotechs continue to emerge despite a challenging market environment that has forced venture firms to build their drug startups more cautiously. Obesity drugs. Zepbound, Mounjaro back in supply as Lilly resolves shortage.

Manufacturing. Pharma. Zydus hit with FDA warning letter flagging glass contamination. After Zydus Lifesciences last week received an FDA Warning Letter, more details about what FDA...

Comprehensive coverage of the pharmaceuticals industry. The latest news and developments from the world's leading drug companies, including Pfizer, Johnson & Johnson, AstraZeneca and more.

Pharma. Latest News. CEO Steps Down from Troubled Ecstasy-Drug Company. The leadership change comes after psychedelic drugmaker Lykos lost its bid for FDA approval. By. Liz Essley Whyte....